News | EP Lab | January 07, 2022

Khaldoun Tarakji Joins Medtronic as Vice President and Chief Medical Officer of Cardiac Ablation Solutions

Khaldoun Tarakji is moving from Cleveland Clinic to Medtronic.

January 7, 2022 — Khaldoun Tarakji, M.D., M.P.H., associate section head of cardiac electrophysiology at the Heart, Vascular, and Thoracic Institute at Cleveland Clinic, has joined Medtronic as the vice president and chief medical officer (CMO) of the Cardiac Ablation Solutions (CAS) Operating Unit at Medtronic.

Tarakji will provide senior level medical expertise, strategic planning and guidance on evidence development, and objective medical and patient safety oversight to ensure technology and therapy effectiveness throughout the product lifecycle. He assumes the role previously held by Rob Kowal, M.D., Ph.D., chief medical officer.

“I am excited to be joining this organization at such a critical juncture in healthcare technology. Never before have we seen such an emphasis on novel technologies to drive improved patient outcomes for arrhythmias,” Tarakji said. “This Medtronic team of engineers and clinical leaders are innovating technologies that are truly advancing care for those suffering from the crippling effects of atrial and ventricular arrhythmias, and I’m excited to support the delivery and access of those therapies. I am also incredibly grateful to the physician and nurse partners of whom I’ve had the pleasure of working alongside during my tenure at Cleveland Clinic, and I look forward to collaborating together again in the future. Most importantly, I am forever grateful to all the patients who entrusted me with their most precious asset, and I hope I continue to serve them on a wider scale in my new role.”

With more than a decade-long career as a cardiac electrophysiologist (EP) at Cleveland Clinic, Tarakji is also a leader in digital health, helping to pioneer cardiovascular patient care via smart device, including remote patient monitoring. He is the founder of the Heart, Vascular & Thoracic Institute Center for Digital Health Technologies and leads a multidisciplinary team of medical experts in exploring and evaluating the potential impact of personal, digital technology to clinical practice. Tarakji holds the roles of associate professor of medicine at Cleveland Clinic Lerner College of Case Western University and director of the Center for International Medical Education at Cleveland Clinic. 

“We are thrilled to welcome Dr. Tarakji to Medtronic,” said Rebecca Seidel, president of the cardiac ablation solutions business, which is part of the cardiovascular portfolio at Medtronic. “Dr. Tarakji is a world-class physician and thought leader in the advanced treatment of atrial fibrillation and other arrhythmias. He’s a long-time advisor and clinical investigator for Medtronic and we are honored that he will be working with us to provide advanced cardiac mapping and ablation solutions for arrhythmia management.”

Watch a recent interview with Dr. Tarakji in the VIDEO: Antibacterial Envelope for EP Devices Reduced Infections in Patients With Hemotomas by 82 Percent.

Find more electrophysiology news and video

 


Related Content

News | Cardiovascular Business

January 24, 2023 — Cardiothoracic surgeon Thomas E. MacGillivray, MD, from MedStar Health, was elected President of The ...

Home January 24, 2023
Home
News | Cardiovascular Business

January 19, 2023 — The volunteers and staff of the American Heart Association and the American Stroke Association are ...

Home January 19, 2023
Home
News | Cardiovascular Business

January 19, 2023 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat ...

Home January 19, 2023
Home
News | Cardiovascular Business

January 11, 2023 — The Alameda, Calif.-based global healthcare company Penumbra has announced U.S. Food & Drug ...

Home January 11, 2023
Home
News | Cardiovascular Business

January 9, 2023 — CinCor Pharma, Inc. announced that it has entered into a definitive agreement with AstraZeneca under ...

Home January 09, 2023
Home
News | Cardiovascular Business

January 9, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the appointment ...

Home January 09, 2023
Home
News | Cardiovascular Business

January 5, 2023 — StreamlineMD has provided updates for 2023 Radiology and IR CPT coding, which may impact your practice ...

Home January 05, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

As 2022 comes to a close, the Diagnostic and Interventional Cardiology team takes a look at the year's most viewed ...

Home January 02, 2023
Home
News | Cardiovascular Business

December 27, 2022 — President Joe Biden signed into law the Cardiovascular Advances in Research and Opportunities Legacy ...

Home December 27, 2022
Home
News | Cardiovascular Business

December 22, 2022 — Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now ...

Home December 22, 2022
Home
Subscribe Now